group,serum,virus,replicate,titer,titer_bound,titer_as,nt50,midpoint,top,bottom,slope
CellVaccineCohort,AUS24_s008_prevax,A/Thies/1247/2023,plate13-AACGAAAAGAATAAGC,40,upper,midpoint,40,40,0.7091,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Thies/1247/2023,plate13-ATTATGTCGTGACAGT,40,upper,midpoint,40,40,0.7511,0,3.901
CellVaccineCohort,AUS24_s008_prevax,A/Pennsylvania/51/2023,plate13-ACCAAAGCTGAATGGA,40,upper,midpoint,40,40,0.7547,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Pennsylvania/51/2023,plate13-ACAGTCGCAGGGAATA,40,upper,midpoint,40,40,0.817,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Philippines/10/2023,plate13-GGTCCACAAGCATCCT,40,upper,midpoint,40,40,0.8494,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Philippines/10/2023,plate13-CCAAGCTAGGTCGACA,40,upper,midpoint,40,40,0.8468,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Norway/8030/2023,plate13-GCGGTATTCATTAATA,40,upper,midpoint,40,40,0.6982,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Norway/8030/2023,plate13-TTTGCTCGCAAAACCA,40,upper,midpoint,40,40,0.8239,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Norway/8030/2023,plate13-GTTTCTGCCTTACAAA,40,upper,midpoint,40,40,0.7653,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Brazil/GIHSN-HCL023128467501/2023,plate13-ATTCGAAGACAGAGGG,40,upper,midpoint,40,40,0.7492,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Brazil/GIHSN-HCL023128467501/2023,plate13-CCTTGCGGTGTTTAAC,40,upper,midpoint,40,40,0.6747,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Panama/M270337/2023,plate13-CAGAACACGATGGAAA,40,upper,midpoint,40,40,0.7524,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Panama/M270337/2023,plate13-GCAGTCTCCGGCTAGG,40,upper,midpoint,40,40,0.7518,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Panama/M270337/2023,plate13-GTCACTATATGATGTC,40,upper,midpoint,40,40,0.8003,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Wisconsin/588/2019,plate13-GAAGAAACTATAACCA,40,upper,midpoint,40.84,40,0.7821,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Wisconsin/588/2019,plate13-TATATTAGTAACATAA,40,upper,midpoint,43.68,40,0.6443,0,5.873
CellVaccineCohort,AUS24_s008_prevax,A/Wisconsin/588/2019,plate13-AGTCCTATCCTCAAAT,40.42,interpolated,midpoint,43.82,40.42,0.723,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Argentina/677/2023,plate13-CGGCAGGATATTGCAG,40,upper,midpoint,40,40,0.7719,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Argentina/677/2023,plate13-ATATCAAGACTAGATG,40,upper,midpoint,40,40,0.7647,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Argentina/677/2023,plate13-CCGTTCTAAAACGCTA,40,upper,midpoint,40,40,0.7399,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Sydney/591/2023,plate13-ATTAGACAATAATGAC,40,upper,midpoint,40,40,0.7165,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Sydney/591/2023,plate13-GGACATCTTTCAAGCA,40,upper,midpoint,40,40,0.7831,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Sydney/591/2023,plate13-CTCTCTACAGTATTGA,40,upper,midpoint,40,40,0.7394,0,3.851
CellVaccineCohort,AUS24_s008_prevax,A/Para/2023-020942-IEC/2023,plate13-TGCATTAATTCAACTA,40,upper,midpoint,40,40,0.8116,0,10
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0053-796776/2023,plate13-TTCTATGTTTCTTTAA,40,upper,midpoint,40,40,0.8002,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0053-796776/2023,plate13-CTCCGCGTGTACAGAT,40,upper,midpoint,40,40,0.8635,0,10
CellVaccineCohort,AUS24_s008_prevax,A/PaisVasco/1994/2023,plate13-TTATCACGTCTTTGCC,40,upper,midpoint,40,40,0.7456,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/PaisVasco/1994/2023,plate13-CGAAAGAACCTACCCG,40,upper,midpoint,40,40,0.7149,0,10
CellVaccineCohort,AUS24_s008_prevax,A/PaisVasco/1994/2023,plate13-CCAGCCACATAAAATT,40,upper,midpoint,40,40,0.6768,0,9.994
CellVaccineCohort,AUS24_s008_prevax,A/Washington/32/2023,plate13-TTGGGGATTGCCCAAA,40,upper,midpoint,40,40,0.8308,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Washington/32/2023,plate13-AAACTCATCAGACTGG,40,upper,midpoint,40,40,0.7066,0,10
CellVaccineCohort,AUS24_s008_prevax,A/NakhonPhanom/P3460/2023,plate13-AAGGAAAATTCAAAGC,40,upper,midpoint,40,40,0.7358,0,9.997
CellVaccineCohort,AUS24_s008_prevax,A/NakhonPhanom/P3460/2023,plate13-CTGTAAAAAGCGTTAA,40,upper,midpoint,40,40,0.6655,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Pennsylvania/46/2023,plate13-AGAAAGCTGTTAATAC,40,upper,midpoint,40,40,0.7875,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Pennsylvania/46/2023,plate13-AAATAATGAGTTTATA,40,upper,midpoint,40,40,0.7661,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Cambodia/KPH230176/2023,plate13-CTGGAATGCAACGGGT,40,upper,midpoint,40,40,0.7871,0,1.5
CellVaccineCohort,AUS24_s008_prevax,A/Cambodia/KPH230176/2023,plate13-AACATGTGTAAGCGGT,40,upper,midpoint,40,40,0.7739,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Cambodia/KPH230176/2023,plate13-ATTTGAACAATGTCCA,40,upper,midpoint,40,40,0.7976,0,9.992
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1423/2023,plate13-ACTGCGTACAGAGGTA,40,upper,midpoint,40,40,0.7711,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1423/2023,plate13-ACGACCAAGTGGTAGT,40,upper,midpoint,40,40,0.7393,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1423/2023,plate13-CACGAAATAGAACGTC,40,upper,midpoint,40,40,0.735,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Valparaiso/41964/2023,plate13-AATGAATGTATGCTAA,40,upper,midpoint,40,40,0.736,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Valparaiso/41964/2023,plate13-TGCCATCTGTGCATTA,40,upper,midpoint,40,40,0.715,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Arizona/IVYG43Q65T3/2023,plate13-TCACAATTCATATAAT,40,upper,midpoint,40,40,0.7638,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Arizona/IVYG43Q65T3/2023,plate13-TAACAGTTAGACAAAA,40,upper,midpoint,40,40,0.7346,0,10
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0348-802602/2023,plate13-ACTTATGCTCTTGATA,40,upper,midpoint,40,40,0.7882,0,10
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0348-802602/2023,plate13-ACTTAGGAAGGTAAAC,40,upper,midpoint,40,40,0.7653,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0348-802602/2023,plate13-TAGTTGACTGTCGAGG,40,upper,midpoint,40,40,0.8186,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Jeonbuk/1544/2023,plate13-GTCATATTCGATTACA,40,upper,midpoint,40,40,0.8508,0,1.5
CellVaccineCohort,AUS24_s008_prevax,A/Jeonbuk/1544/2023,plate13-AAAGCCCTAGTTAAGT,40,upper,midpoint,40,40,0.8414,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1382/2023,plate13-ATTATGGAAATAATGA,40,upper,midpoint,40,40,0.7148,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1382/2023,plate13-CAGGACGCAAAACACA,40,upper,midpoint,40,40,0.6976,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1382/2023,plate13-CCCTATCCCAGAACCT,40,upper,midpoint,40,40,0.7515,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Cambodia/SVH230198/2023,plate13-GTCTAACAAGAATGTA,40,upper,midpoint,40,40,0.7298,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Cambodia/SVH230198/2023,plate13-ATAGCATGCGATTTTA,40,upper,midpoint,40,40,0.756,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1834/2023,plate13-CAAGGAAGTCAGGATT,40,upper,midpoint,40,40,0.8952,0,9.271
CellVaccineCohort,AUS24_s008_prevax,A/SouthAfrica/R06646/2023,plate13-ACCTATTCTATTTTTC,40,upper,midpoint,40,40,0.7889,0,10
CellVaccineCohort,AUS24_s008_prevax,A/SouthAfrica/R06646/2023,plate13-ACTTAAAATCTTATAA,40,upper,midpoint,40,40,0.7819,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Chungbuk/1553/2023,plate13-TTACCTCTGAGAAACG,40,upper,midpoint,40,40,0.7746,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Chungbuk/1553/2023,plate13-AGCCCTTAAGACATTA,40,upper,midpoint,40,40,0.787,0,9.997
CellVaccineCohort,AUS24_s008_prevax,A/Chungbuk/1553/2023,plate13-AAATTAAAGAGGTTAA,40,upper,midpoint,40,40,0.7874,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0048-796565/2023,plate13-CACGAGTTGGTGGGTT,40,upper,midpoint,40,40,0.7726,0,10
CellVaccineCohort,AUS24_s008_prevax,A/CostaRica/INC-0048-796565/2023,plate13-CAATCCGCTTGAATAC,40,upper,midpoint,40,40,0.7908,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Netherlands/1739/2023,plate13-ACTAAAGGCATAGTAG,40,upper,midpoint,40,40,0.702,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Netherlands/1739/2023,plate13-TCTATCATCGCCGTTA,40,upper,midpoint,40,40,0.719,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Singapore/GP7085/2023,plate13-AAAGTGAGACCTGTAC,40,upper,midpoint,40,40,0.7475,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/2241/2023,plate13-TATTCAACATTCTCTA,40,upper,midpoint,40,40,0.7806,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1384/2023,plate13-CGCATGCAATTATAAA,40,upper,midpoint,40,40,0.8087,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1384/2023,plate13-CAAAAACTTTAATTTC,40,upper,midpoint,40,40,0.8179,0,10
CellVaccineCohort,AUS24_s008_prevax,A/ChiangRai/P3437/2023,plate13-AAACTGATTAATGATG,40,upper,midpoint,40,40,0.7196,0,10
CellVaccineCohort,AUS24_s008_prevax,A/ChiangRai/P3437/2023,plate13-AATGATAACTTAAAAA,40,upper,midpoint,40,40,0.6943,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Arizona/43/2023,plate13-TGTGATAGACCTAGAA,40,upper,midpoint,40,40,0.9106,0,9.998
CellVaccineCohort,AUS24_s008_prevax,A/Perth/372/2023,plate13-TTATAAAAACAAATCG,40,upper,midpoint,40,40,0.7499,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1389/2023,plate13-TTTTAGATAAACTTAG,40,upper,midpoint,40,40,0.7229,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Denmark/1567/2023,plate13-TAGTAATCTAAAGTAA,40,upper,midpoint,40,40,0.734,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Denmark/1567/2023,plate13-TCCGAAAGACCAAAAC,40,upper,midpoint,40,40,0.8011,0,10
CellVaccineCohort,AUS24_s008_prevax,A/EspiritoSanto/6964/2023,plate13-TGGCCTGCTTCGGAAA,40,upper,midpoint,40,40,0.8682,0,9.271
CellVaccineCohort,AUS24_s008_prevax,A/EspiritoSanto/6964/2023,plate13-AAATAAGTATCCTAAA,40,upper,midpoint,40,40,0.6842,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/EspiritoSanto/6964/2023,plate13-AGCATCACGTCAGTCT,40,upper,midpoint,40,40,0.7779,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Oregon/32/2023,plate13-ATTGTGAAGAATTGCT,40,upper,midpoint,40,40,0.6904,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Oregon/32/2023,plate13-CGTATACAAACGCGAC,40,upper,midpoint,40,40,0.7237,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Argentina/824/2023,plate13-TACTAAGTAAGAGCAA,40,upper,midpoint,40,40,0.6765,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Norway/7787/2023,plate13-ATATGTGCTAACAAAA,40,upper,midpoint,40,40,0.6825,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1013/2023,plate13-ATATTGTTAATATTCT,40,upper,midpoint,40,40,0.719,0,10
CellVaccineCohort,AUS24_s008_prevax,A/NewHampshire/7/2023,plate13-TGAACTAGACTTTCAA,40,upper,midpoint,40,40,0.7333,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/NewHampshire/7/2023,plate13-AAGTAGTGATTAAGCA,40,upper,midpoint,40,40,0.7393,0,10
CellVaccineCohort,AUS24_s008_prevax,A/NewHampshire/7/2023,plate13-CTGCACTCCGTAAATT,40,upper,midpoint,40,40,0.7711,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Tasmania/140/2023,plate13-CAACGGATTCTTGTTG,40,upper,midpoint,40,40,0.7016,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Wisconsin/67/2022,plate13-AAAGCTCTTTTCGTTC,40,upper,midpoint,40,40,0.8117,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1010/2023,plate13-AATTTTAGGACGCCGT,40,upper,midpoint,40.08,40,0.7092,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/1010/2023,plate13-TCCCTTAGGCATAGCC,40,upper,midpoint,40,40,0.6498,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Norway/9845/2023,plate13-TGAAGCCATGAGTATC,40,upper,midpoint,40,40,0.816,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/California/75/2023,plate13-CTTCAAAGACTGATTA,40,upper,midpoint,40,40,0.758,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/California/75/2023,plate13-AGCCCGAAGAGCCCCT,40,upper,midpoint,40,40,0.888,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Senegal/1341/2023,plate13-TAAAGACAAAAAAACC,40,upper,midpoint,40,40,0.7009,0,9.997
CellVaccineCohort,AUS24_s008_prevax,A/Michigan/MISAPPHIREL365374393/2023,plate13-ATCCCATCAACAAAAT,40,upper,midpoint,40,40,0.7078,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Michigan/MISAPPHIREL365374393/2023,plate13-GGATTGTAATAAATCA,40,upper,midpoint,40,40,0.7381,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Sydney/130/2023,plate13-CCATAACTGTATATGG,40,upper,midpoint,40,40,0.7123,0,9.999
CellVaccineCohort,AUS24_s008_prevax,A/Gwangju/1254/2023,plate13-GTCAAATAAATTTTCA,40,upper,midpoint,40,40,0.6879,0,10
CellVaccineCohort,AUS24_s008_prevax,A/RioGrandedoSul/6798/2023,plate13-AATCCATTAGTTCAGC,40,upper,midpoint,40,40,0.851,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Hawaii/70/2019,plate13-TGGAATCGTCACCGAT,78.21,interpolated,midpoint,81.86,78.21,0.8167,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Hawaii/70/2019,plate13-AGTAAACATGCATTGG,79.29,interpolated,midpoint,85.27,79.29,0.7415,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Hawaii/70/2019,plate13-ATAGAATCGCAAATTA,79.82,interpolated,midpoint,85.78,79.82,0.7431,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Victoria/4897/2022_IVR238,plate13-AAGTTAAGAGAAAGTT,77.54,interpolated,midpoint,81.1,77.54,0.8192,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Oregon/Flu-OHSU-241140095/2023,plate13-CAAGGAAACCGGTTGA,40.88,interpolated,midpoint,43.89,40.88,0.7459,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Oregon/Flu-OHSU-241140095/2023,plate13-AGCAGTAAATAAAATC,41.8,interpolated,midpoint,45.31,41.8,0.7236,0,10
CellVaccineCohort,AUS24_s008_prevax,A/Brisbane/02/2018,plate13-TAATAAGCCAGCAAGA,136.5,interpolated,midpoint,178.2,136.5,0.68,0,3.836
CellVaccineCohort,AUS24_s008_prevax,A/Brisbane/02/2018,plate13-TTGGGCACTAAATTAA,138.1,interpolated,midpoint,190.1,138.1,0.6221,0,4.416
CellVaccineCohort,AUS24_s008_prevax,A/Brisbane/02/2018,plate13-ATCCGATTTAAAGGCA,102.3,interpolated,midpoint,115,102.3,0.6823,0,8.634
CellVaccineCohort,AUS24_s008_prevax,A/Michigan/45/2015,plate13-ACAAAGTCTCGAGAAG,190.2,interpolated,midpoint,247.3,190.2,0.613,0,5.657
CellVaccineCohort,AUS24_s008_prevax,A/Michigan/45/2015,plate13-TTGAAAAAATCATAAA,236.9,interpolated,midpoint,387.6,236.9,0.6123,0,3.033
CellVaccineCohort,AUS24_s008_prevax,A/Michigan/45/2015,plate13-CACCTAGGATCGCACT,219.7,interpolated,midpoint,289,219.7,0.6971,0,3.395
CellVaccineCohort,AUS24_s008_prevax,A/California/07/2009,plate13-GACACAGAACCCATGC,326.2,interpolated,midpoint,373,326.2,0.6308,0,10
CellVaccineCohort,AUS24_s008_prevax,A/California/07/2009,plate13-CATGTGAATTCGCCCA,330.7,interpolated,midpoint,377.2,330.7,0.6342,0,10
CellVaccineCohort,AUS24_s008_prevax,A/California/07/2009,plate13-CCTTTCTCAAAACATA,372.8,interpolated,midpoint,464.8,372.8,0.673,0,4.813
